$1.17
-0.07[-5.65%]
At close: May 28
$1.17
0[0.00%]
After Hours: 7:59AM EDT
Hepion Pharmaceuticals
(NASDAQ:HEPA)Latest News for Hepion Pharmaceuticals Stock (NASDAQ:HEPA)
Hepion Pharmaceuticals Stock (NASDAQ: HEPA)
Categories: All
Monday, April 22, 2024
- S&P 500 Rises Over 1%; Zions Bancorp Shares Gain After Q1 EarningsAvi Kapoor - Apr 22, 2024, 2:46PM
- Why Is Liver-Disease Drug Developer Hepion Pharmaceuticals Stock Trading Lower On Monday?Vandana Singh - Apr 22, 2024, 2:14PM
- Why Vaxxinity Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day SessionAvi Kapoor - Apr 22, 2024, 1:26PM
- 12 Health Care Stocks Moving In Monday's Intraday SessionBenzinga Insights - Apr 22, 2024, 12:31PM
- Gold Falls Sharply; Matterport Shares Spike HigherAvi Kapoor - Apr 22, 2024, 12:07PM
- Dow Jumps Over 100 Points; Chicago Fed National Activity Rises In MarchAvi Kapoor - Apr 22, 2024, 9:41AM
- 12 Health Care Stocks Moving In Monday's Pre-Market SessionBenzinga Insights - Apr 22, 2024, 8:07AM
- Hepion Pharmaceuticals shares are trading lower after the company announced that it began wind-down activities in its Phase 2b "ASCEND-NASH Trial.Benzinga Newsdesk - Apr 22, 2024, 7:46AM
Friday, April 19, 2024
- Hepion Pharmaceuticals Says Given The Number Of Enrolled NASH Patients To Date And The Low Probability Of Generating Relevant Efficacy Data To Support A Registrational Trial With Our Current Cash Resources, We Have Opted To Wind Down The Program And Assure That Patients Are Transitioned Out Of The Trial In A Safe And Compliant Manner"Benzinga Newsdesk - Apr 19, 2024, 5:06PM
- Hepion Pharmaceuticals Shares Resumed TradingBenzinga Newsdesk - Apr 19, 2024, 5:05PM
- Trading Halt: Halt status updated at 4:55:00 PM ET: Quotation Resumption: News and Resumption TimesBenzinga Newsdesk - Apr 19, 2024, 4:55PM
- Hepion Pharmaceuticals Initiates Wind-Down Activities In Phase 2b 'ASCEND-NASH' TrialBenzinga Newsdesk - Apr 19, 2024, 4:33PM
- Trading Halt: Halted at 4:25:20 p.m. ET - Trading Halt: Halt News PendingBenzinga Newsdesk - Apr 19, 2024, 4:25PM
Monday, February 19, 2024
Friday, February 16, 2024
Thursday, February 15, 2024
Tuesday, December 12, 2023
Thursday, December 07, 2023
- Brookline Capital Downgrades Hepion Pharmaceuticals to HoldBenzinga Newsdesk - Dec 7, 2023, 2:22PM
- Hepion Pharmaceuticals Shares Resume TradeBenzinga Newsdesk - Dec 7, 2023, 8:30AM
- Hepion Pharm, Inc. Shares To Resume Trade At 8:30 a.m. ETBenzinga Newsdesk - Dec 7, 2023, 8:08AM
- Hepion Pharmaceuticals Announces Restructuring Plan To Enhance Shareholder Value And Management Changes; Reducing Operating Costs By ~60% Going Forward. Hepion Will Incur A One-Time Restructuring Charge Of ~$400K–$800K That Will Be Recorded In Q4 Of 2023Benzinga Newsdesk - Dec 7, 2023, 8:04AM
Monday, November 13, 2023
Friday, September 29, 2023
Thursday, September 21, 2023
Friday, September 15, 2023
Thursday, September 14, 2023
Thursday, June 15, 2023
Thursday, May 25, 2023
Tuesday, May 23, 2023
Monday, May 22, 2023
- Tesla, Zoom, Hepion, Pfizer, ZIM: Why These 5 Stocks Are Drawing Investor Attention TodayBhavik Nair - May 22, 2023, 9:22PM
- 12 Health Care Stocks Moving In Monday's Intraday SessionBenzinga Insights - May 22, 2023, 1:31PM
- Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Monday's Mid-Day SessionLisa Levin - May 22, 2023, 1:20PM
- US Stocks Mixed; Nordic American Tankers Posts Upbeat ResultsLisa Levin - May 22, 2023, 9:50AM
- 12 Health Care Stocks Moving In Monday's Pre-Market SessionBenzinga Insights - May 22, 2023, 9:06AM
- Why Hepion Pharmaceuticals Stock Is Soaring MondayAdam Eckert - May 22, 2023, 8:33AM
- Hepion Pharmaceuticals shares are trading higher after the company announced results of its phase 2 study to treat liver function.Benzinga Newsdesk - May 22, 2023, 8:11AM
- Why Immix Biopharma Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving PremarketLisa Levin - May 22, 2023, 8:06AM
- Hepion Pharmaceuticals' Phase 2 'ALTITUDE-NASH' Trial Achieves Primary and Secondary EndpointsBenzinga Newsdesk - May 22, 2023, 7:03AM
- Hepion Pharmaceuticals Shares Surge 75% Ahead Of Monday Conference Call to Review Topline Results from Phase 2 ALTITUDE NASH Liver Function Trial of RencofilstatCharles Gross - May 22, 2023, 4:48AM